Our Therapies

The first and only FDA-approved
treatment for Demodex blepharitis

SEC Filing Details

Document Details

Form
Filing Date
March 14, 2022
Document Date
December 31, 2021
Form Description
Annual report which provides a comprehensive overview of the company for the past year
Filing Group
Annual Filings
Company
Tarsus Pharmaceuticals
Issuer
TARSUS PHARMACEUTICALS, INC.